MENINGVAX / CLINICAL SCIENCE / 012
PREVENTION · INTERVENTION · RECOVERY

Meningitis
Prevention &
Treatment

From immunological protection to urgent clinical intervention: the evidence-based principles that reduce meningitis risk, guide treatment, and support recovery.

EXPLORE PREVENTION ↗ VIEW TREATMENT PATHWAYS
CLINICAL PRINCIPLE

Prevention reduces risk. Early recognition and appropriate treatment can be lifesaving.

01 / PREVENTION SCIENCE

Prevention begins before exposure.

Meningitis has multiple infectious causes. Prevention combines organism-specific vaccination, infection-control measures, and targeted protection after certain exposures.

P / 01

Vaccination

MenACWY, MenB, pneumococcal, and Hib vaccines protect against important bacterial causes. Eligibility and timing depend on age, risk, and local recommendations.

Explore vaccines →
P / 02

Exposure control

Hand hygiene, respiratory etiquette, and avoiding shared saliva exposures can help reduce transmission of some meningitis-associated pathogens.

P / 03

Contact prophylaxis

Close contacts of people with invasive meningococcal disease may need prompt preventive antibiotics, regardless of vaccination status, as directed by public health authorities.

P / 04

Risk-based protection

Infants, certain immunocompromised people, and individuals with specific medical or exposure risks may require tailored prevention strategies.

!
02 / CLINICAL URGENCY

Suspected bacterial meningitis is a medical emergency.

Fever, severe headache, neck stiffness, confusion, seizures, or rapid deterioration require urgent medical assessment. A rash may occur in meningococcal disease, but its absence does not exclude meningitis.

Clinicians coordinate rapid investigations and prompt empiric antimicrobial treatment when bacterial meningitis is suspected. Treatment should not be delayed solely to complete diagnostic testing.

03 / TREATMENT PATHWAYS

The cause determines the treatment.

Meningitis is a syndrome, not a single infection. Treatment depends on the suspected or confirmed pathogen, illness severity, and the patient's clinical circumstances.

Bacterial meningitis TIME-CRITICAL
Prompt intravenous antibiotics, supportive hospital care, and selected adjunctive therapies according to clinical guidelines. Treatment is refined when microbiology results become available.
Viral meningitis CAUSE-DEPENDENT
Many cases improve with supportive care. Specific antivirals may be indicated for particular infections, including selected herpesvirus-associated cases.
Fungal meningitis SPECIALIST CARE
Requires organism-specific antifungal therapy, often over an extended period, with management of complications such as increased intracranial pressure when present.
Non-infectious meningitis UNDERLYING CAUSE
Management addresses the underlying inflammatory, medication-related, or other cause after an appropriate diagnostic evaluation excludes important infections.

This comparison summarizes clinical principles; it is not an individual treatment protocol.

04 / RESEARCH TRANSLATION

What clinical evidence tells us.

GUIDELINE EVIDENCE

Rapid antimicrobial care

WHO guidance emphasizes rapid diagnosis, appropriate antimicrobial treatment, supportive care, and follow-up for people affected by meningitis.

WHO guidelines, 2025 ↗
RANDOMIZED CLINICAL TRIAL

Adjunctive corticosteroids

Adult trials have investigated dexamethasone alongside antibiotics. Its benefit varies by pathogen and clinical setting; use follows current medical guidance.

de Gans & van de Beek, NEJM, 2002 ↗
LONG-TERM OUTCOMES

Recovery extends beyond discharge

Bacterial meningitis can leave hearing, neurological, or cognitive complications. Appropriate follow-up is part of comprehensive care.

Long-term outcomes research ↗
05 / CONTINUITY OF CARE

Survival is not the final endpoint.

Recovery may require monitoring for hearing changes, neurological symptoms, learning difficulties, fatigue, or other lasting effects. Follow-up is individualized according to the infection and its complications.

RECOVERY ASSESSMENT DOMAINS
01   Hearing and communication
02   Neurological functioning
03   Cognitive and developmental health
04   Rehabilitation and quality of life
06 / COMMON QUESTIONS

Frequently asked questions

Can meningitis be completely prevented?

No. Vaccines prevent disease caused by specific pathogens or serogroups, but no single vaccine prevents every form of meningitis.

Are antibiotics effective against all meningitis?

No. Antibiotics treat bacterial infections; viral, fungal, and non-infectious causes require different approaches.

Do close contacts always need preventive antibiotics?

No. Preventive treatment depends on the organism, type of exposure, and public-health recommendations. Close contacts of meningococcal cases may require prompt prophylaxis.

SCIENTIFIC SOURCES

References & clinical guidance

  1. World Health Organization. WHO Guidelines on Meningitis Diagnosis, Treatment and Care. 2025. Read guidelines.
  2. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine. 2002. PubMed.
  3. Nguyen THM, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine. 2007. PubMed.
  4. Research on long-term outcomes following childhood bacterial meningitis. PubMed.
  5. Centers for Disease Control and Prevention. About Bacterial Meningitis. CDC.
  6. Centers for Disease Control and Prevention. About Viral Meningitis. CDC.
  7. Centers for Disease Control and Prevention. Meningococcal Disease: Surveillance and Chemoprophylaxis. CDC.
CONTINUE THE SCIENTIFIC EXPLORATION

Explore related evidence

MeningVax publishes educational scientific content. This material does not replace medical diagnosis or treatment. Seek emergency medical care if meningitis is suspected.